Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity

• Päätekijät: Libo Zhao (Tekijä), Cong Cai (Tekijä), Jing Wang (Tekijä), Liming Zhao (Tekijä), Weijin Li (Tekijä), Changyu Liu (Tekijä), Hanfeng Guan (Tekijä), Yuanli Zhu (Tekijä), Jun Xiao (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2017-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Dihydromyricetin (DMY), the main flavonoid component of Ampelopsis grossedentata, possesses pharmacological activities useful for treatment of diseases associated with inflammation and oxidative damage. Because osteoclasts are often involved in chronic low-grade systemic inflammation and oxidative d...